SCHEMBL7729236

SCHEMBL7729236

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
TRPV1 Q8NER1 4/20 0.40
HDAC8 Q9BY41 4/20 0.40
HDAC3 O15379 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
EPHX2 P34913 1/20 0.40
RAB9A P51151 3/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ABL1 P00519 3/20 0.39
BCR P11274 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7727582 0.89 HDAC1 (0.47) HDAC4HDAC1HDAC8HDAC3HDAC7
SCHEMBL7722336 0.87 SCN9A (0.36) HDAC4HDAC1TRPV1HDAC8HDAC3
SCHEMBL7731670 0.87 SCN9A (0.36) HDAC4HDAC1TRPV1HDAC8HDAC3
SCHEMBL7722254 0.83 POLB (0.46) HDAC4HDAC1TRPV1HDAC8HDAC3
SCHEMBL7722250 0.83 POLB (0.46) HDAC4HDAC1TRPV1HDAC8HDAC3
SCHEMBL7731725 0.82 HDAC8 (0.44) HDAC8POLBABL1BCRMEN1
SCHEMBL7728662 0.82 DPP4 (0.42) MEN1KMT2A
SCHEMBL7728992 0.82 POLB (0.56) HDAC4HDAC1TRPV1HDAC8HDAC3
SCHEMBL7728996 0.82 POLB (0.56) HDAC4HDAC1TRPV1HDAC8HDAC3
SCHEMBL7726525 0.82 POLB (0.56) HDAC4HDAC1TRPV1HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed